Skip to main content
. 2022 Jun 30;13:813791. doi: 10.3389/fendo.2022.813791

Table 3.

Reproductive outcomes per embryo transfer.

Characteristic NC HRT GnRH-a+HRT (n = 846) P
(n = 4306) (n = 1007)
Clinical pregnancy rate   2103/4306 (48.8%) 483/1007 (48.0%) 399/846 (47.1%) 0.633
Implantation rate   2464/6051 (40.7%) 549/1400 (39.2%) 461/1213 (38.0%) 0.162
Heterotopic   28/2103 10/483 5/399 0.444
pregnancy -1.33% -2.30% -1.25%
Twins and multiple pregnancies   312/4306 (7.25%) 52/1007 33/846* <0.001
-5.16% -3.90%
Miscarriage rates(1st or 2nd trimester)   481/2103 (22.9%) 132/483 (27.3%) 90/399 0.101
-22.60%
  1st 394/2103 (18.7%) 117/483 (24.2%)* 74/399 0.021
trimester -18.50%
  2nd trimester 87/2103 15/483 16/399 0.576
-4.14% -3.11% -4.01%
  Miscarriage rate of singleton pregnancies 428/2103 (20.4%) 123/483 (25.5%)* 79/399 0.036
-19.80%
  Miscarriage rate of multiple pregnancies 53/2103 9/483 11/399 0.632
-2.52% -1.86% -2.76%
Stillbirths   2/2103 (0.0951%) 0 1/399 0.5
-0.25%
Live birth rate   1595/4306 (37.0%) 343/1007 (34.1%) 302/846 (35.7%) 0.19
Singletons   1402/4306 (32.6%) 307/1007 (30.5%) 269/846 0.437
-31.80%
Twins   193/4306 (4.48%) 36/1007 (3.57%) 33/846 0.377
-3.90%
Preterm births   214/2103 (10.2%) 57/483 36/399 0.383
-11.80% -9.02%

*Compared to the NC, P < 0.05; # = compared to the HRT cycle, P < 0.05; NC, natural cycle; HRT, hormone replacement therapy; GnRH-a, gonadotropin-releasing hormone agonist.